Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,768.00
Bid: 2,768.00
Ask: 2,770.00
Change: -8.00 (-0.29%)
Spread: 2.00 (0.072%)
Open: 2,780.00
High: 2,792.00
Low: 2,760.00
Prev. Close: 2,776.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Debt

13 May 2019 16:38

RNS Number : 8720Y
Coca-Cola HBC AG
13 May 2019
 

Coca-Cola HBC Finance B.V.

(the "Issuer")

(a private limited liability company incorporated in the Netherlands)

Guaranteed by:

Coca-Cola HBC AG

("Guarantor")

(a company incorporated with limited liability in Switzerland)

 

Publication of Final Terms dated 13 May 2019

 

Zug, Switzerland and Amsterdam, The Netherlands - 13 May 2019 - The following Final Terms are available for viewing:

· Final Terms dated 13 May 2019 in respect of the €700,000,000 aggregate principal amount of 1.000% Notes due 2027; and

· Final Terms dated 13 May 2019 in respect of the €600,000,000 aggregate principal amount of 1.625% Notes due 2031,

to be issued by Coca-Cola HBC Finance B.V. under its €5 billion Euro Medium Term Note Programme, and guaranteed by Coca-Cola HBC AG.

To view the Final Terms and the Base Prospectus, please paste the following URL into the address bar of your browser.

http://www.coca-colahellenic.com/investorrelations/Debtholders/Fundingsources/ 

The Final Terms have also been submitted to the National Storage Mechanism and will shortly be available for inspection at: http://www.morningstar.co.uk/uk/NSM.

Disclaimer

The Notes have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold within the United States or to or for the account or benefit of U.S. persons except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Accordingly, the Notes will be offered only in offshore transactions to non-U.S. persons in reliance upon Regulation S under the Securities Act.

 

Your right to access this service is conditional upon complying with the above requirements.

 

 

Enquiries

Coca‑Cola HBC Group

Joanna Kennedy

Investor Relations Director

Tel: +44 20 37 444 230

 joanna.kennedy@cchellenic.com

Vasso Aliferi

Investor Relations Manager

Tel: +41 44 835 9274

 vasso.aliferi@cchellenic.com

 

Carla Fabiano

Investor Relations Manager

Tel: +44 20 37 444 231

carla.fabiano@cchellenic.com

 

 

 

About Coca‑Cola HBC

Coca-Cola HBC is a leading bottler of The Coca-Cola Company with an annual sales volume of more than 2 billion unit cases. It has a broad geographic footprint with operations in 28 countries serving a population of more than 600 million people. Coca-Cola HBC offers a diverse range of primarily non-alcoholic ready-to-drink beverages in the sparkling, juice, water, sport, energy, tea and coffee categories. Coca-Cola HBC is committed to promoting sustainable development in order to create value for its business and for society. This includes providing products that meet the beverage needs of consumers, fostering an open and inclusive work environment, conducting its business in ways that protect and preserve the environment and contribute to the socio-economic development of the local communities. Coca-Cola HBC is ranked among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG and FTSE4Good, among others.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and its shares are listed on the Athens Exchange (ATHEX: EEE). For more information, please visit http://www.coca-colahellenic.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IODEASSDFDFNEFF
Date   Source Headline
9th Jul 20203:03 pmRNSNotice of Results
7th Jul 20204:45 pmRNSCCH names Naya Kalogeraki Chief Operating Officer
1st Jul 202010:09 amRNSTotal Voting Rights
30th Jun 202011:21 amRNSDirector/PDMR Shareholding
25th Jun 20203:38 pmRNSDirector/PDMR Shareholding
18th Jun 20202:35 pmRNSDirector/PDMR Shareholding
18th Jun 20207:42 amRNSCFO to step down in the first quarter of 2021
16th Jun 20203:54 pmRNSDirector/PDMR Shareholding
16th Jun 20201:42 pmRNSComposition of the Committees of the BoD
16th Jun 20201:06 pmRNSResult of AGM
12th Jun 20201:59 pmRNSAthens Exchange trading date of ordinary shares
9th Jun 20209:40 amRNSDirector/PDMR Shareholding
19th May 20201:08 pmRNSDirector/PDMR Shareholding
14th May 20207:00 amRNSAGM notice, changes to the BoD and dividend dates
11th May 20205:39 pmRNSPublication of Suppl.Prospcts
7th May 20207:00 amRNSKEEPING OUR PEOPLE SAFE AND CUSTOMERS SERVED
1st May 202010:36 amRNSBlock listing Interim Review
30th Apr 20204:13 pmRNSDirector/PDMR Shareholding
30th Apr 20203:59 pmRNSPublication of a Prospectus
27th Apr 20205:42 pmRNSDisclosure of Rights attached to Equity Shares
21st Apr 20201:00 pmRNSDirector/PDMR Shareholding
14th Apr 20203:33 pmRNSNotice of Results
9th Apr 20205:45 pmRNSTotal Voting Rights - Replacement
9th Apr 20205:18 pmRNSTotal Voting Rights
27th Mar 20201:10 pmRNSDirector/PDMR Shareholding
27th Mar 20207:00 amRNSCovid-19 update and actions
19th Mar 20203:39 pmRNSDirector/PDMR Shareholding
19th Mar 20203:01 pmRNSDirector/PDMR Shareholding
19th Mar 202011:16 amRNSWhat it takes to deliver 24/7
18th Mar 20201:36 pmRNSDirector/PDMR Shareholding
2nd Mar 20201:39 pmRNSissue of equity and total voting rights
20th Feb 202012:25 pmRNSDirector/PDMR Shareholding
19th Feb 20203:04 pmRNSDirector/PDMR Shareholding
18th Feb 20202:17 pmRNSDirector/PDMR Shareholding
13th Feb 20207:00 amRNSQ4 ACCELERATION AND ANOTHER STRONG YEAR
7th Feb 20204:03 pmRNSNotice of Results - New time for the analysts call
3rd Feb 20209:21 amRNSIssue of equity and total voting rights
20th Jan 20203:27 pmRNSDirector/PDMR Shareholding
17th Jan 20209:26 amRNSNotice of Results
8th Jan 20202:01 pmRNSAthens Exchange trading date of ordinary shares
18th Dec 20192:00 pmRNSDirector/PDMR Shareholding
13th Dec 20191:50 pmRNSJoint Venture
6th Dec 20196:14 pmRNSCompletion of the acquisition of Lurisia
19th Nov 20193:31 pmRNSIssue of Debt
19th Nov 20192:10 pmRNSDirector/PDMR Shareholding
14th Nov 20195:49 pmRNSIssue of Debt
14th Nov 20198:44 amRNSIssue of Debt
13th Nov 20191:11 pmRNSPublication of Suppl.Prospcts
13th Nov 20197:00 amRNSSOLID QUARTER DESPITE ADVERSE WEATHER CONDITIONS
1st Nov 20199:41 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.